文献速递妇科生殖医学

多囊卵巢综合征中中度至重度抑郁和焦虑症状的高患病率:系统综述与Meta分析

High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.
PubMed 文献 · Hum Reprod · 2017-01-01

该系统综述与Meta分析纳入截至2016年1月的30项横断面研究,包括3050例多囊卵巢综合征(PCOS)女性和3858名对照。结果显示PCOS女性中度至重度抑郁症状的OR为4.18(95%CI 2.68-6.52),中度至重度焦虑症状的OR为6.55(95%CI 2.87-14.93),按BMI匹配后仍升高。作者建议医疗服务提供者应考虑对PCOS女性进行抑郁和焦虑筛查。

要点

  • PCOS女性中度至重度抑郁症状的OR为4.18(95%CI 2.68-6.52;11项研究)。
  • PCOS女性中度至重度焦虑症状的OR为6.55(95%CI 2.87-14.93;5项研究)。
  • 按BMI匹配后PCOS女性抑郁(OR 3.25;95%CI 1.73-6.09)和焦虑(OR 6.30;95%CI 1.88-21.09)的OR仍升高。

核心结论

  • PCOS诊断与中度至重度抑郁和焦虑症状风险增加相关,且独立于肥胖。
  • 作者建议医疗服务提供者应考虑对PCOS女性进行抑郁和焦虑筛查。

研究设计与样本

  • 系统综述检索截至2016年1月,纳入30项横断面研究,含3050例PCOS女性和3858名对照,来自10个国家。
  • 抑郁症状Meta分析纳入18项研究,焦虑症状Meta分析纳入9项研究;另有一项系统综述纳入15项研究用于Meta回归。
  • 纳入研究为成年PCOS女性(NIH或Rotterdam标准)及无PCOS对照组,使用经验证的筛查工具。

主要发现

  • PCOS女性任何抑郁症状的OR为3.78(95%CI 3.03-4.72;18项研究),中度至重度抑郁症状的OR为4.18(95%CI 2.68-6.52;11项研究)。
  • PCOS女性任何焦虑症状的OR为5.62(95%CI 3.22-9.80;9项研究),中度至重度焦虑症状的OR为6.55(95%CI 2.87-14.93;5项研究)。
  • 按BMI匹配后,PCOS女性抑郁症状OR为3.25(95%CI 1.73-6.09;4项研究),焦虑症状OR为6.30(95%CI 1.88-21.09;3项研究)。
  • 抑郁症状总体Meta分析异质性不显著(I²=22.4%,P=0.19),焦虑症状分析异质性显著(I²=59.6%,P=0.01)。
  • Meta回归显示,PCOS伴抑郁者年龄、BMI、多毛评分和IR均值更高;PCOS伴焦虑者BMI、多毛评分和游离睾酮均值更高(所有比较P<0.05)。

关键数值与推荐

  • PCOS诊断采用NIH或Rotterdam标准。
  • 抑郁和焦虑症状采用经验证的筛查工具评估。

临床怎么用

  • 作者认为,医疗服务提供者应考虑对PCOS女性进行抑郁和焦虑筛查。
  • 作者指出,年龄、肥胖、高雄激素血症和IR不能解释全部关联。

局限性

  • 所有研究均为横断面研究,因此只能推测PCOS诊断先于抑郁和焦虑诊断。
  • 方法学特征存在较大变异,尤其在焦虑筛查研究中,但仅部分解释了效应量变异。
  • 需要精心设计的研究评估治疗这些因素对PCOS女性抑郁和焦虑症状的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Do women with polycystic ovary syndrome (PCOS) have an increased prevalence of moderate and severe depressive and anxiety symptoms compared with control women, and do these symptoms correlate with age, BMI, testosterone, hirsutism or insulin resistance (IR)? SUMMARY ANSWER: Women with PCOS have significantly increased odds of moderate and severe depressive and anxiety symptoms, independent of obesity, and the symptoms are weakly associated with age, BMI, elevated testosterone, hirsutism and IR. WHAT IS KNOWN ALREADY: Previous studies have reported that women with PCOS have an increased prevalence of mild depressive and anxiety symptoms or an increase in mean depression and anxiety scores, although these scores are usually within the normal range. Thus, it is therefore not clear whether these findings are clinically significant. The prevalence of moderate and severe depressive and anxiety symptoms, which require follow-up and would benefit from treatment, is not known in this population. STUDY DESIGN, SIZE, DURATION: A comprehensive systematic review (SR) was performed up to January 2016 and included 30 cross-sectional studies, representing 3050 subjects with PCOS and 3858 controls, from 10 different countries. The meta-analysis (MA) on depressive symptoms included 18 studies and the MA on anxiety symptoms included 9 studies. A separate SR identified 15 studies for the meta-regression examining the associations with PCOS-related symptoms or comorbidities. PARTICIPANTS/MATERIALS, SETTING, METHODS: All studies included adult women with PCOS, defined by the National Institutes of Health or Rotterdam criteria, and a control group without PCOS. Ovid, Embase, PsychInfo and Cochrane were searched up to January 2016. Included studies used a validated screening tool to compare the prevalence or mean scores of depressive and/or anxiety symptoms. Random effects MA was used to estimate the pooled odds ratio (OR) of depressive and anxiety symptoms. Sensitivity analyses of methodological characteristics and a meta-regression of the pooled standardized mean difference (SMD) to evaluate PCOS-related clinical and laboratory associations were performed. MAIN RESULTS AND THE ROLE OF CHANCE: Women with PCOS had increased odds of any depressive symptoms (OR: 3.78; 95% CI: 3.03-4.72; 18 studies) and of moderate/severe depressive symptoms (OR: 4.18; 95% CI: 2.68-6.52; 11 studies). Women with PCOS had increased odds of any anxiety symptoms (OR: 5.62; 95% CI: 3.22-9.80, nine studies) and of moderate/severe anxiety symptoms (OR: 6.55; 95% CI: 2.87, 14.93; five studies). When subjects were matched on BMI, women with PCOS still had higher odds of both depressive (OR: 3.25; 95% CI 1.73-6.09; four studies) and anxiety symptoms (OR: 6.30, 95% CI: 1.88-21.09; three studies). There was no substantial heterogeneity among studies in the overall MA on depressive symptoms (I2 = 22.4%, P = 0.19), but there was significant heterogeneity among studies in the analysis on anxiety symptoms (I2 = 59.6%, P= 0.01). In the meta-regression evaluating pooled SMDs between groups, women with PCOS and concurrent depression had higher mean values of age, BMI, hirsutism score and IR, while women with PCOS and concurrent anxiety had higher mean values of BMI, hirsutism score and free testosterone (P < 0.05 for all comparisons). LIMITATIONS, REASON FOR CAUTION: All studies were cross-sectional, thus we can only hypothesize that the diagnosis of PCOS precedes the diagnosis of depression and anxiety. There were large variations in methodological characteristics especially in the studies screening for anxiety; however, they only partly explained effect size variation. WIDER IMPLICATIONS OF THE FINDINGS: This evidence-synthesis analysis shows that PCOS diagnosis is associated with an increased risk of moderate and severe depressive and anxiety symptoms and suggests that providers should consider screening women with PCOS for both depression and anxiety. Although age, obesity, hyperandrogenism and IR do not explain the entire association, well-designed studies are needed to assess the impact of treatment of these factors on depressive and anxiety symptoms in women with PCOS. STUDY FUNDING/COMPETING INTEREST(S): No funding was used for this study. There are no conflicts of interest. REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Cooney LG, Lee I, Sammel MD, et al. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2017. PMID: 28333286. doi:10.1093/humrep/dex044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。